Faruqi & Faruqi Encourages Coty Investors to Reach Out
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 01 2026
0mins
Should l Buy COTY?
Source: PRnewswire
- Legal Action Reminder: Faruq & Faruqi LLP is investigating potential claims against Coty Inc., specifically for investors who purchased or acquired securities between November 5, 2025, and February 4, 2026, urging them to seek lead plaintiff status by the May 22, 2026 deadline to protect their legal rights.
- Investor Loss Focus: Securities Litigation Partner Josh Wilson encourages affected investors to contact him directly, providing two phone numbers to help them understand their legal options and seek potential compensation, demonstrating a commitment to investor rights.
- Firm Background: Founded in 1995, Faruqi & Faruqi is a leading national securities law firm that has recovered hundreds of millions of dollars for investors, showcasing its expertise and successful track record in securities litigation.
- Legal Consultation Channels: Investors can reach out to Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) or visit the firm's website for more information, ensuring they receive timely legal support.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COTY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COTY
Wall Street analysts forecast COTY stock price to rise
12 Analyst Rating
1 Buy
9 Hold
2 Sell
Hold
Current: 2.200
Low
2.50
Averages
4.30
High
10.00
Current: 2.200
Low
2.50
Averages
4.30
High
10.00
About COTY
Coty Inc. is a beauty company with a portfolio of brands across fragrance, color cosmetics, and skin and body care. The Company has a diverse portfolio of brands, which includes both owned and licensed. Its brand portfolio is classified into two segments: Consumer beauty and Prestige. The consumer beauty brands include Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Mexx, LeGer by Lena Gercke, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, and Vera Wang. Its prestige brands include Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, and Tiffany & Co. Its mass beauty brands are primarily sold through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, traditional food and drug retailers, and dedicated e-commerce retailers. It markets, sells and distributes its products in over 120 countries and territories.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Legal Action Reminder: Faruq & Faruqi LLP is investigating potential claims against Coty Inc., specifically urging investors who purchased securities between November 5, 2025, and February 4, 2026, to seek lead plaintiff status by the May 22, 2026 deadline.
- Investor Loss Focus: Partner James (Josh) Wilson encourages affected investors to contact him directly, providing two phone numbers, which demonstrates the firm's commitment to supporting investor rights and addressing their concerns.
- Company Background: Coty Inc. is listed on the NYSE, and since its founding in 1995, Faruqi & Faruqi has recovered hundreds of millions of dollars for investors, showcasing its expertise in securities law.
- Commitment to Legal Services: With offices in New York, Pennsylvania, California, and Georgia, Faruqi & Faruqi emphasizes its capability to provide nationwide legal support to investors, aiming to help them protect their legal rights.
See More
- Cost Pressure: The collapse of Iran peace talks has led to increased raw material costs for food companies, with Kraft Heinz expecting a 4% rise in input costs this year, directly impacting its profit margins.
- Market Overreaction: Despite the stock market's sharp reaction, with MGP Ingredients and Freshpet falling 4.8% and 5.5% respectively, this may present buying opportunities for investors looking for quality stocks.
- Freshpet Financial Performance: Freshpet reported a 14% year-over-year increase in net sales for Q3, reaching $288.8 million, exceeding analyst expectations and demonstrating strong market demand and profitability.
- Stock Price Volatility: Freshpet has declined 16.3% year-to-date, currently trading at $50.34, which is 43.8% below its 52-week high of $89.64, reflecting market caution regarding its future performance.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE:COTY) common stock between November 5, 2025, and February 4, 2026, that they must apply to be lead plaintiff by May 22, 2026, to participate in the class action and seek compensation.
- Fee Arrangement: Investors joining the Coty class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, thereby reducing the financial burden on investors.
- Lawsuit Background: The lawsuit alleges that Coty made false and misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, which resulted in investor losses once the truth was revealed.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first for the number of securities class action settlements in 2017, demonstrating its expertise and success in this field.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE: COTY) common stock between November 5, 2025, and February 4, 2026, that they must apply to be lead plaintiff by May 22, 2026, to participate in the class action and seek compensation.
- Fee Arrangement: Investors joining the Coty class action will incur no upfront costs, as the law firm operates on a contingency fee basis, allowing investors to pursue legal remedies without financial burden.
- Lawsuit Background: The lawsuit alleges that Coty made false and misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, which led to investor losses when the truth emerged, highlighting the company's underperformance in the consumer beauty sector.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, demonstrating its extensive experience and success in handling such cases.
See More
- Lufax Class Action: Lufax Holding Ltd. is facing allegations for failing to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, which may undermine investor confidence due to misleading positive statements about the company's prospects.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. is under scrutiny for not disclosing manufacturing issues and risks associated with its clinical trials from May 20, 2024, to January 9, 2026, potentially jeopardizing FDA approval of its key product and significantly impacting its financial condition.
- Coty Legal Issues: Coty Inc. faces claims for failing to reveal underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, which may affect investor confidence due to misleading statements regarding the company's business operations.
- Legal Consultation Reminder: The Law Offices of Frank R. Cruz remind investors that those who suffered losses during the specified periods can contact them for legal advice to ensure their rights are protected in these class actions.
See More
- Disappointing Earnings: Coty's Q2 fiscal 2026 results revealed a 6% decline in net revenue year-over-year, a 200 basis point drop in gross margins, and a 19% decrease in adjusted operating income, indicating performance below market expectations and undermining investor confidence.
- Outlook Downgrade: The company withdrew its 2026 EBITDA guidance and anticipates a gross margin decline of 200 to 300 basis points in Q3, with expected earnings per share near breakeven, reflecting increased operational pressures that could impact shareholder returns.
- Management Changes: Newly appointed interim CEO Markus Strobel acknowledged the company has not delivered as expected and emphasized the need for investment in operational effectiveness and marketing support, highlighting the urgency in strategic execution.
- Legal Action: The class action lawsuit against Coty alleges that the company failed to disclose critical information regarding underperformance in its Consumer Beauty segment and slowing market growth, potentially exposing investors to greater losses and increasing legal risks.
See More











